Menu
Currency
GWAS Study

Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes.

Vollenbrock CE, Roshandel D, van der Klauw MM et al.

36536295 PubMed ID
GWAS Study Type
27254 Participants
33 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VC
Vollenbrock CE
RD
Roshandel D
VD
van der Klauw MM
WB
Wolffenbuttel BHR
PA
Paterson AD
Chapter II

Abstract

Summary of the research findings

Skin autofluorescence (SAF) is a non-invasive measure reflecting accumulation of advanced glycation endproducts (AGEs) in the skin. Higher SAF levels are associated with an increased risk of developing type 2 diabetes and cardiovascular disease. An earlier genome-wide association study (GWAS) revealed a strong association between NAT2 variants and SAF. The aim of this study was to calculate SAF heritability and to identify additional genetic variants associated with SAF through genome-wide association studies (GWAS).

27,254 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

27254
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Netherlands
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.